Form 4: Astera Labs CFO Sells Shares to Cover Tax Obligations

Michael Truett Tate, CFO of Astera Labs, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Michael Truett Tate, the Chief Financial Officer of Astera Labs, sold 34,474 shares of common stock at a weighted average price of $92.0702.
• The sale was to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units.
• Following the transaction, Tate directly owns 244,242 shares and indirectly owns 1,370,596 shares through the Tate Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, not necessarily indicative of the CFO's outlook on the company's performance.

Industry Context

Form 4 filings are a routine part of insider trading activity and are closely monitored by investors for signals about a company's prospects. This particular filing relates to a 'sell to cover' transaction, which is a common practice to manage tax obligations associated with equity compensation.

Stakeholder Impact

• The sale of shares by the CFO could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the reason for the sale.

Key Dates

Keywords

Astera Labs, ALAB, Michael Truett Tate, CFO, Form 4, Share Sale, Tax Withholding, Restricted Stock Units, Tate Trust, Beneficial Ownership